Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized Study

Advances in Therapy ◽

10.1007/s12325-017-0626-4 ◽

2017 ◽

Vol 34 (11) ◽

pp. 2518-2533 ◽

Author(s):

Gregory J. Feldman ◽

Ana R. Sousa ◽

David A. Lipson ◽

Lee Tombs ◽

Neil Barnes ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Randomized Study ◽

Chronic Obstructive ◽

Comparative Efficacy ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Comparative Efficacy of Once-Daily Umeclidinium and Twice-Daily Salmeterol in Symptomatic Patients with Chronic Obstructive Pulmonary Disease Free of Inhaled Corticosteroids: Results from the EMAX Trial

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3320 ◽

2019 ◽

Author(s):

E.M. Kerwin ◽

C. Vogelmeier ◽

L. Bjermer ◽

F. Maltais ◽

M.L. Watkins ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Inhaled Corticosteroids ◽

Chronic Obstructive ◽

Comparative Efficacy ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Faculty Opinions recommendation of Health coaching and chronic obstructive pulmonary disease rehospitalization. A randomized study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726204702.793517387 ◽

2016 ◽

Author(s):

Hajime Takizawa ◽

Masato Watanabe

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Randomized Study ◽

Health Coaching ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text

Bayesian Network Meta-Analysis To Assess The Comparative Efficacy And Safety Of Treatments For Chronic Obstructive Pulmonary Disease

Value in Health ◽

10.1016/j.jval.2015.09.1383 ◽

2015 ◽

Vol 18 (7) ◽

pp. A495

Author(s):

V Taieb ◽

D Belhadi ◽

AT Nielsen ◽

M Hemels ◽

J Van Laer

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Bayesian Network ◽

Pulmonary Disease ◽

Meta Analysis ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Obstructive Pulmonary Disease

Download Full-text

A Comparison of Tiotropium 18µg, Once Daily and Ipratropium 40µg, 4 Times Daily in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults with Chronic Obstructive Pulmonary Disease

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2005.58.5.498 ◽

2005 ◽

Vol 58 (5) ◽

pp. 498 ◽

Author(s):

Seung Joon Kim ◽

Myung Sook Kim ◽

Sang Haak Lee ◽

Young Kyoon Kim ◽

Hwa Sik Moon ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Prospective randomized study of the effect of nebivolol on the incidence of late invasive mechanical ventilation in ischemic heart disease patients with acute exacerbation of chronic obstructive pulmonary disease

Research and Opinion in Anesthesia and Intensive Care ◽

10.4103/roaic.roaic_5_16 ◽

2017 ◽

Vol 4 (2) ◽

pp. 54

Author(s):

BishoyT.T Tadross ◽

MahmoudI Mahmoud ◽

AkramM Fayed

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Mechanical Ventilation ◽

Heart Disease ◽

Ischemic Heart Disease ◽

Pulmonary Disease ◽

Acute Exacerbation ◽

Randomized Study ◽

Invasive Mechanical Ventilation ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Download Full-text

Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease

Respiratory Medicine ◽

10.1016/j.rmed.2019.05.010 ◽

2019 ◽

Vol 153 ◽

pp. 38-43 ◽

Author(s):

James F. Donohue ◽

Edward Kerwin ◽

Sanjay Sethi ◽

Brett Haumann ◽

Srikanth Pendyala ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Phase 3 ◽

Obstructive Pulmonary Disease ◽

Muscarinic Antagonist ◽

Download Full-text

Prevention of Exacerbations of Chronic Obstructive Pulmonary Disease with Tiotropium, a Once-Daily Inhaled Anticholinergic Bronchodilator: A Randomized Trial

Yearbook of Pulmonary Disease ◽

10.1016/s8756-3452(08)70339-6 ◽

2007 ◽

Vol 2007 ◽

pp. 92-93

Author(s):

J.R. Maurer

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Randomized Trial ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Anticholinergic Bronchodilator

Download Full-text

Once daily Long-acting beta2 -agonists/Inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease

Cochrane Database of Systematic Reviews ◽

10.1002/14651858.cd012355 ◽

2016 ◽

Author(s):

Agnieszka Sliwka ◽

Milosz Jankowski ◽

Iwona Gross-Sondej ◽

Roman Nowobilski ◽

Malgorzata M Bala

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Inhaled Corticosteroids ◽

Chronic Obstructive ◽

Muscarinic Antagonists ◽

Obstructive Pulmonary Disease ◽

Download Full-text

Once-daily glycopyrronium bromide, a long-acting muscarinic antagonist, for chronic obstructive pulmonary disease: a systematic review of clinical benefit

International Journal of Chronic Obstructive Pulmonary Disease ◽

10.2147/copd.s35990 ◽

2012 ◽

pp. 673 ◽

Author(s):

Charlotte Ulrik

Keyword(s):

Systematic Review ◽

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Clinical Benefit ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Muscarinic Antagonist ◽

Glycopyrronium Bromide ◽

Download Full-text

Randomized study of the efficacy and safety of SUN11031 (synthetic human ghrelin) in cachexia associated with chronic obstructive pulmonary disease

e-SPEN Journal ◽

10.1016/j.clnme.2012.07.004 ◽

2012 ◽

Vol 7 (5) ◽

pp. e171-e175 ◽

Author(s):

Benjamin Levinson ◽

Joseph Gertner

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Randomized Study ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Obstructive Pulmonary Disease

Download Full-text